Trial Profile
Adjuvant rituximab; a potential treatment for the young patient with Graves' hyperthyroidism
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Carbimazole; Propylthiouracil
- Indications Graves' disease
- Focus Therapeutic Use
- Acronyms RIGD
- 28 Nov 2020 Status changed from active, no longer recruiting to completed.
- 12 Dec 2019 Status changed from recruiting to active, no longer recruiting.
- 30 Sep 2016 New trial record